Estee Lauder Share Price: Live EL Stock Quote, Chart & Forecast

Estée Lauder stock has shed roughly $15 billion in market value since confirming merger talks with Spain’s Puig in late March 2026, with shares plummeting 17% in just two sessions as investors weigh the risks of a multibillion-euro deal against the company’s ongoing restructuring. The stock now trades near $78, well below its 52-week high of $121.64, leaving investors to decide whether this represents a genuine buying opportunity or a value trap.

Current Price: $77.95 (open) · 52-Week High: $121.64 · 52-Week Low: $56.66 · Market Cap: $27.64B · Shares Outstanding: 247.22M

The key facts below summarize the current state of Estée Lauder stock as of the latest trading session.

Is Estee Lauder stock a buy or sell?

Analyst opinions on Estée Lauder split widely, reflecting genuine uncertainty about whether the company can navigate its turnaround while also pulling off a multibillion-euro merger. The stock trades far below where it was a year ago, yet the deal with Spanish fragrance company Puig has added a fresh layer of complexity that investors haven’t fully priced in.

Analyst ratings

Six firms have published targets in recent months, with the range spanning from cautious to moderately bullish. J.P. Morgan set the high-water mark at $121 on February 6, 2026 (Andrea Teixeira), while Wells Fargo’s Christopher Carey assigned $90 on March 24, 2026. TD Cowen’s Oliver Chen sits at $115, Deutsche Bank’s Steve Powers at $108, Citigroup’s Filippo Falorni at $120, and Barclays’ Lauren Lieberman at $94.

Morningstar values the stock at a fair $120, representing a 34% discount to that estimate given current trading levels. Goldman Sachs had issued a Buy rating back in October 2025, though market conditions and deal chatter have shifted materially since then.

Buy sell or hold consensus

TipRanks currently lists a Hold recommendation as appropriate, citing “substantial execution risk due to deal scale, structure uncertainty.” The site notes that balancing risk and reward amid Estée Lauder-Puig deal uncertainty supports the hold stance rather than an aggressive buy or sell. For retail investors, this uncertainty-weighted consensus suggests patience over action.

Why is Estee Lauder dropping?

The stock’s decline isn’t just about broader market weakness. Estée Lauder has been dealing with a multiyear turnaround that has taken longer than expected, and then the company announced something that made investors even more nervous: potential acquisition talks with Puig.

Recent share obliteration

When Estée Lauder confirmed it was exploring a transaction with Puig on March 23, 2026, shares fell 8% in a single session. By the next day, the total decline reached 17%, with the stock closing at $71.48. According to BeautyMatter, Estée Lauder’s recovery narrative “unraveled since confirming talks with Puig, wiping out roughly $15 billion in market value.”

The divergence was stark: Puig shares rose 14% on the initial merger news, while Estée Lauder shares moved sharply in the opposite direction. Beauty Independent noted that “Puig stock mid-single digits up, Estée Lauder high-single digits down on deal news” — a classic sign that investors view the deal as more of a burden than a benefit for the acquirer.

Puig deal impact

The deal structure has investors worried for several reasons. J.P. Morgan has reportedly been commissioned to arrange a €5 billion financing package, according to Investing.com. That kind of financing at Estée Lauder’s current debt levels raises questions about leverage.

Morningstar provides context on the numbers: “Estée Lauder net leverage 2.6x, $1.5 billion projected 2026 FCF; may need $6 billion new shares (20% dilution).” Simply Wall St analysis warns that “a multibillion euro financing package could increase debt levels and interest costs at a time when analysts already flag a high level of debt as a risk.”

The integration complexity adds another layer. Simply Wall St notes that “integration risks in beauty involve complex brand positioning and extended restructuring costs.” Estée Lauder is already mid-restructuring with charges continuing through March 31, 2026.

What is the stock price prediction for Estee Lauder in 2026?

Forecasting Estée Lauder through 2026 means accounting for two overlapping uncertainties: the outcome of restructuring efforts already underway, and whether the Puig deal advances to a binding agreement or collapses.

Analyst predictions

The analyst targets cited above represent the professional consensus for where the stock might trade assuming current conditions persist. However, these targets were set before the March 23 deal confirmation and the subsequent share decline to $71.48.

StockInvest.us, a tier-3 source, notes a “sell signal from pivot top on July 10, 2025” with the stock having fallen since. The same source expected an open of $76.09 on April 24, 2026, with a recommended stop-loss at $86.65. These signals are directional but should be weighed against higher-tier research from Morningstar and Quiver Quantitative.

Price targets

Morningstar’s fair value estimate of $120 carries particular weight given the firm’s tier-1 status. That 34% discount to fair value — if accurate — suggests the market is pricing in a worst-case scenario around deal financing and restructuring costs.

Quiver Quantitative reports that multiple firms issued price targets in early 2026 before the deal confirmation: J.P. Morgan at $121, Citigroup at $120, TD Cowen at $115, Deutsche Bank at $108, Barclays at $94, and Wells Fargo at $90. The current stock price below $78 sits below all six targets, which is unusual and suggests the market has moved more bearish than Wall Street consensus.

The implication is that the stock may have overshot on the downside, though that doesn’t mean a rebound is imminent if deal uncertainty persists.

Can Estee Lauder recover?

Estée Lauder has been in a multiyear turnaround that has tested investor patience. The company is working through restructuring charges that extend through March 31, 2026, according to Quiver Quantitative. Add in the Puig deal chatter and the picture gets more complicated.

Turnaround doubts

Quiver Quantitative observes that “investors have been sensitive to deal-related uncertainty because the company is still working through a multiyear turnaround.” That’s the core problem: investors who were already nervous about the turnaround now have to factor in deal execution risk at the same time.

The financing required for the Puig deal could add billions in new debt to a company already carrying significant leverage. Morningstar estimates the combined entity would have $20 billion in sales and a 17% EBITDA margin, but getting there requires clearing substantial integration hurdles.

Storm over but risks

One reading of the situation: the worst stock decline may be behind us. The 17% two-day drop on deal news is the sharpest repricing, and subsequent trading near $77–$78 suggests some stabilization. The company confirmed it was exploring a transaction, not that a deal was certain.

Simply Wall St notes that the stock has returned 37.8% over the past year — but that figure masks the more recent damage. Year-to-date decline stands at 28.9%, and the five-year decline is 74.1%. For long-term investors who bought at higher prices, the recovery question isn’t academic.

The pattern suggests that even if the deal falls through, Estée Lauder still faces the fundamental challenge of proving its restructuring can deliver results.

Is Estee Lauder undervalued?

At first glance, a stock trading below $78 after hitting $121.64 looks like a bargain. But value investors learn to ask why a stock has fallen — and whether the decline reflects temporary setbacks or permanent impairment. To understand if Estee Lauder is undervalued, consider its current share price and forecast at $Classifica banche italiane.

Reassessing valuation

Morningstar places fair value at $120, suggesting the stock trades at a significant discount. Using that estimate, current levels represent roughly a 35% discount to intrinsic value. That sounds attractive until you consider that Morningstar issued that estimate before the deal confirmation introduced new execution risks.

The company’s net leverage sits at 2.6x with projected 2026 free cash flow of $1.5 billion. Adding €5 billion in new financing would push that ratio materially higher. Simply Wall St’s analysis frames it this way: “a multibillion euro financing package could increase debt levels and interest costs at a time when analysts already flag a high level of debt as a risk.”

Prolonged share price decline

The five-year chart tells a cautionary story. Estée Lauder stock has declined 74.1% over that span, a period that included the post-pandemic boom in prestige beauty and its subsequent slowdown. The company expanded aggressively during the boom years and is now dealing with the aftermath.

Shares that trade at $77 today were above $300 at various points in 2021. The decline reflects both multiple compression (investors paying lower price-to-earnings multiples as growth slowed) and earnings uncertainty during the restructuring. Beauty Independent reports the combined entity could have “$40 billion market value, $20 billion sales, 50 brands” — but that future depends on deal execution that remains uncertain.

The five-year trajectory suggests that investors who expected a smoother recovery have been repeatedly disappointed, raising questions about whether the current discount is warranted or reflects deeper structural challenges.

Timeline

Three major inflection points have defined Estée Lauder stock in the past 12 months.

The upcoming earnings report on April 24 will be the next major catalyst. Investors are watching for whether the restructuring is delivering results, and whether the company provides clarity on the Puig deal timeline.

What analysts and publications are saying

“Investors have been sensitive to deal-related uncertainty because the company is still working through a multiyear turnaround.”

— Quiver Quantitative (Financial Analysis)

“Estée Lauder’s recovery narrative has unraveled since confirming talks with Puig, wiping out roughly $15 billion in market value.”

— BeautyMatter (Industry Editorial)

“If completed, a Puig merger would lift Estee’s market share in premium fragrance to 15% from 6%.”

— Morningstar (Equity Research)

“A multibillion euro financing package could increase debt levels and interest costs at a time when analysts already flag a high level of debt as a risk.”

— Simply Wall St (Investment Analysis)

The pattern across these sources suggests that while the strategic logic of the deal has merit, the financing and execution risks are substantial enough to keep many investors on the sidelines.

Bottom line

Estée Lauder stock has been under severe pressure, with the shares getting obliterated on deal news and remaining under a cloud of uncertainty. The company is trying to execute a multiyear restructuring at the same time it pursues a potentially transformative but risky deal with Puig.

The analyst community is genuinely split: some see a discount worth betting on, while others point to execution risks that could make the discount a value trap. Morningstar’s 34% discount to fair value looks attractive on paper, but only if the deal succeeds and the turnaround stays on track.

For long-term investors, the stock sits at levels that represent real opportunity — provided you have high conviction in the company’s ability to manage both the restructuring and the merger simultaneously. For shorter-term traders, the April 24 earnings report and any deal announcements between now and then will likely move the stock more than fundamentals alone.

Related reading: DBS Share Price Today · Standard Chartered Journey Credit Card

Frequently asked questions